Immune system deregulation and evasion play a key role in cancers' evolution and
progression, including squamous cell carcinoma of the head and neck (SCCHN) …

Full article: Immunotherapy for Head and Neck Cancer: Where do We Go from Here? Skip to Main
Content Taylor and Francis Online homepage Taylor and Francis Online homepage Log in …

Head and neck squamous cell carcinoma (HNSCC) is an immunosuppressive disease with
multiple mechanisms to impair immune-mediated recognition and control of tumor cell …

Recent advances have permitted successful therapeutic targeting of the immune system in
head and neck squamous cell carcinoma (HNSCC). These new immunotherapeutic targets …

Immunotherapy in head and neck tumors: new options in advanced disease and beyond Page
1 www.jumdjournal.net Review Open Access Quenelle et al. J Unexplored Med Data 2018;3:7 …

The concept of immunotherapy as a treatment for cancer patients has been in existence for
decades. However, more recent immune therapeutic approaches have involved targeting of …

Squamous cell cancer of the head and neck (HNSCC) is the sixth most common cancer and
is associated with significant morbidity and mortality. The tumor microenvironment for …

It was estimated that 59,340 new cases of head and neck cancer would be diagnosed in the
US alone in 2015 and that 12,290 deaths would be attributed to the disease. Local and …

Introduction: Head and neck squamous cell carcinoma (HNSCC) is the sixth most common
cancer worldwide with> 500,000 cases diagnosed each year. HNSCC patients often present …

Head-and-neck squamous cell carcinoma (HNSCC) consists of biologically aggressive
tumors of a heterogeneous group. Despite the advances made in the surgical and …